-
Mashup Score: 0Rural Oncologists' Perceptions of Specialty Scarcity and Repercussions for Care Delivery: A Qualitative Study | JCO Oncology Practice - 7 hour(s) ago
PURPOSETo understand oncology physician perceptions of and experiences with specialist scarcity in their referral networks, strategies for delivering care after the departure of a colleague who they view as critical to their cancer care networks (ie, a …
Source: ascopubs.orgCategories: General Medicine NewsTweet
-
Mashup Score: 9High-Deductible Health Plans and Out-of-Pocket Health Care Costs Among Younger Patients With Multiple Myeloma | JCO Oncology Practice - 1 day(s) ago
PURPOSEThis study aimed to determine if high-deductible health plan (HDHP) enrollment contributes to financial burden and hinders access to care for patients with multiple myeloma (MM).MATERIALS AND METHODSPatients diagnosed with MM from 2010 to 2020 were …
Source: ascopubs.orgCategories: General Medicine NewsTweet
-
Mashup Score: 0
PURPOSEMany cancer survivors consume alcohol above recommended limits, increasing their risk of recurrence, second cancers, and cancer-related mortality. Alcohol screening, brief intervention, and referral to treatment (SBIRT) is a guideline-recommended …
Source: ascopubs.orgCategories: General Medicine NewsTweet
-
Mashup Score: 2Symptom Management for Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline | JCO Oncology Practice - 6 day(s) ago
ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO Guidelines Methodology Manual. ASCO Guidelines follow …
Source: ascopubs.orgCategories: General Medicine NewsTweet
-
Mashup Score: 0
PURPOSEEffective methods to improve body composition and metabolic/hormonal dysregulation are central to breast cancer care. We hypothesized that a nutrition regimen focused on food quality and an observed exercise regimen using high-load resistance …
Source: ascopubs.orgCategories: General Medicine NewsTweet
-
Mashup Score: 1Development and Validation of a Cell-Free DNA Fragmentomics–Based Model for Early Detection of Pancreatic Cancer - 12 day(s) ago
PURPOSEPancreatic ductal adenocarcinoma (PDAC), known for its high fatality rate, is often diagnosed in its advanced stages where surgical options are not viable. This highlights the critical need for innovative and effective early detection techniques. …
Source: ascopubs.orgCategories: General Medicine NewsTweet
-
Mashup Score: 1
PURPOSEThere is a volume-outcome association in cancer surgery; fulfillment of minimum surgical caseloads (MSCs) is known to be associated with reduced in-hospital mortality. To our knowledge, to date, there is no evidence-based approach to determine MSC …
Source: ascopubs.orgCategories: General Medicine NewsTweet
-
Mashup Score: 0An Oncologist's Guide to Ensuring Your First Medical Grand Rounds Will Be Your Last | JCO Oncology Practice - 19 day(s) ago
The following represents disclosure information provided by the author of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO’s conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/op/authors/author-center. Open Payments is a public database containing
Source: ascopubs.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
PURPOSETo compare demographics, clinical characteristics, health care resource utilization (HCRU), treatment duration, and overall survival (OS) with enzalutamide (ENZA) or abiraterone acetate (AA) in patients with metastatic castration-resistant prostate …
Source: ascopubs.orgCategories: General Medicine NewsTweet
-
Mashup Score: 7Germline and Somatic Genomic Testing for Metastatic Prostate Cancer: ASCO Guideline Clinical Insights | JCO Oncology Practice - 25 day(s) ago
Prostate cancer is a major cause of disease burden, with an estimated 313,780 new cases (the highest incidence in males aside from skin cancer, comprising 30% of all new cases) and approximately 33,363 deaths (the second highest cause of mortality in males and constituting 11% of all cancer-related deaths) in the United States in 2025. 1 As with many other cancers, somatic genomic testing has both prognostic and predictive capabilities and may affect treatment decision making for patients with metastatic
Source: ascopubs.orgCategories: General Medicine NewsTweet
Rural Oncologists’ Perceptions of Specialty Scarcity and Repercussions for Care Delivery: A Qualitative Study. Read full article. https://t.co/o0aLRVwUlE